Powder: -20°C for 3 years | In solvent: -80°C for 1 year
S 2720 is a human immunodeficiency virus type 1 (HIV-1)-specific reverse transcriptase (RT) inhibitor quinoxaline.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 6-8 weeks | $ 1,520.00 | |
50 mg | 6-8 weeks | $ 1,980.00 | |
100 mg | 6-8 weeks | $ 2,500.00 |
Description | S 2720 is a human immunodeficiency virus type 1 (HIV-1)-specific reverse transcriptase (RT) inhibitor quinoxaline. |
Molecular Weight | 310.8 |
Formula | C14H15ClN2O2S |
CAS No. | 146739-86-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
S 2720 146739-86-8 S-2720 EPZ 6438 monohydrochloride EPZ-6438 monohydrochloride S2720 Tazemetostat HCl EPZ6438 monohydrochloride inhibitor inhibit